The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Boosting long-term immune responses to sipuleucel-T (sip-T) by retreatment of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Churchill Pharmaceuticals; Dendreon; Janssen Biotech; Janssen Oncology; Janssen Research & Development; La Roche Ltd
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio; Sotio (Inst); Theraclone Sciences (Inst)
 
John Corman
Research Funding - Dendreon
 
Raymond S. Lance
Consulting or Advisory Role - Medivation
Speakers' Bureau - Medivation
 
Dwayne Campogan
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Tuyen Vu
No Relationships to Disclose
 
Heather Haynes
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
Research Funding - Dendreon
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Nadeem Anwar Sheikh
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Brendan D. Curti
Honoraria - Prometheus
Speakers' Bureau - Prometheus
Research Funding - Bristol-Myers Squibb; Galectin Therapeutics; MedImmune; Prometheus; Viralytics
Travel, Accommodations, Expenses - Agonox; MedImmune; Nektar; Prometheus